Search results for: 'research area dna damage atm kinase'
- L1042P DiscoveryProbe™ Immunology/Inflammation Compound Library PlusSummary: A unique collection of 806 small molecule compounds for immunology/inflammation research.
- L1042 DiscoveryProbe™ Immunology/Inflammation Compound LibrarySummary: A unique collection of 295 small molecule compounds for immunology/inflammation research.
- L1047 DiscoveryProbe™ Angiogenesis LibrarySummary: A unique collection of 84 small molecule compounds for angiogenesis research.
- BA9236 SLU-PP-1072Summary: SLU-PP-1072 is a dual inverse agonist for prostate cancer (PCa) research.
- BA4983 TivanisiranSummary: Tivanisiran (SYL1001) is an siRNA that can be used in dry eye research.
- A8649 NU 7026Target: PI3K|DNA-PK|ATMSummary: DNPK inhibitor,ATP-competitive and potent
- A8544 Wortmannin5 CitationSummary: PI3K inhibitor,selective and irreversible
- B7443 (5Z)-7-Oxozeaenol1 CitationTarget: TAK1Summary: TAK1 mitogen-activated protein kinase kinase kinase (MAPKKK) inhibitor
- BA1552 HeliquinomycinSummary: Heliquinomycin is an inhibitor of DNA deconjugase (6.8 μM) and inhibits DNA and RNA synthesis.
- BA1605 EnocitabineSummary: Enocitabine, a nucleoside analog, is a potent DNA replication inhibitor and DNA chain terminator.